| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1998;29:2347-2351.)
© 1998 American Heart Association, Inc.
Original Contributions |
From the Heart Disease Department (F.A., F.C., M.S.) and the Neurological Sciences Department (G. di B., F.F.G.), S. Filippo Neri Hospital, Rome, Italy.
Correspondence to Fabrizio Ammirati, MD, Via Attilio Friggeri, 95, 00136 Roma, Italy. E-mail fabamm{at}tin.it
| Abstract |
|---|
|
|
|---|
MethodsEEG monitoring was performed during head-up tilt testing in a group of 63 consecutive patients (27 males and 36 females; mean age, 41.5 years) with a history of recurrent syncope of unknown origin despite extensive clinical and laboratory assessment.
ResultsSyncope occurred in 27 of 63 patients (42.8%) during head-up tilt testing and was found to be cardioinhibitory in 11 of 27 (40.7%) and vasodepressor in 16 of 27 (59.3%). All patients with a negative response to head-up tilt testing showed no significant EEG modifications. In patients with vasodepressor syncope, a generalized high-amplitude, 4- to 5-Hz (theta range) slowing of EEG activity appeared at the onset of syncope, followed by an increase of brain-wave amplitude with the reduction of frequency at 1.5 to 3 Hz (delta range). The return to the supine position was associated with brain-wave amplitude reduction and frequency increase to 4 to 5 Hz, followed by restoration of a normal EEG pattern and arousal (mean total duration of syncope, 23.2 seconds.). In patients with cardioinhibitory syncope, a generalized high-amplitude EEG slowing in the theta range was noted at the onset of syncope, followed by a brain-wave amplitude increase and slowing in the delta range. A sudden reduction of brain-wave amplitude then ensued, leading to the disappearance of electrocerebral activity ("flat" EEG). The return to the supine position did not allow either the immediate resolution of EEG abnormalities or consciousness recovery, both of which occurred after a further time interval (mean total duration of syncope, 41.4 seconds.).
ConclusionsEEG monitoring during head-up tilt testing allowed recording and systematic description of electrocerebral abnormalities developing in the course of tilt-induced vasovagal syncope.
Key Words: electroencephalography syncope tilt table test
| Introduction |
|---|
|
|
|---|
EEG allows dynamic assessment of neurological function,4 while head-up tilt testing is currently used to induce a vasovagal syncope in susceptible individuals.5 6 Accordingly, the main hypothesis for the present clinical investigation was that the introduction of EEG monitoring during head-up tilt testing could significantly improve the understanding of the cerebral events occurring during tilt-induced vasovagal syncope and the potential danger that could be caused to the patient by this diagnostic procedure.
| Subjects and Methods |
|---|
|
|
|---|
All patients were included if they had suffered at least 2 episodes of syncope during the preceding 6 months. In all cases the cause of syncope had not been established despite extensive clinical and laboratory evaluation, including history, physical examination, neurological assessment, full routine laboratory tests, 12-lead standard ECG, exercise ECG, Doppler echocardiography, 24-hour ECG monitoring, EEG, and duplex ultrasound scanning of the carotid arteries. Carotid sinus massage was performed for 10 seconds on each side of the neck separately and was negative in all patients. Moreover, when clinically indicated, CT scans (in 47 patients) and MR imaging (9 patients) of the central nervous system and cardiac electrophysiological study (5 patients) had also been performed. Through such diagnostic workup, any cardiac, neurological, and metabolic diseases were ruled out in all cases.
The 63 patients and a control group of 10 asymptomatic, healthy subjects (6 females and 4 males; mean age, 35.5±12.4 years) with no history of syncope in their lifetime provided informed consent and were submitted to the head-up tilt testing protocol currently used at our institution, which includes EEG monitoring during the whole procedure. Both patients and controls were free of any medication prior and during the whole study period.
The test was performed in the morning, in fasting state. A 20-g heparinated cannula was inserted in the antecubital vein in all patients before the diagnostic procedure. An electronically controlled tilt table (Ferrox VDE 0551, CIAR s.r.l.), with a foot-board for weight-bearing and restraining belts, was used for the procedure; such a device takes 10 to 18 seconds to reach the horizontal position from a 60° incline, depending on patient weight. Continuous ECG monitoring for heart rate and rhythm was performed, while a standard mercury sphygmomanometer was used to measure blood pressure at 5-minute intervals throughout the test. However, in case of symptom development blood pressure measurement was performed at 1-minute intervals. Continuous EEG monitoring was performed by a standard Esaote Biomedica Vega 24 device with electrodes placed according to the international 10-20 System with 18 channels of recording.7 Electrodes were held in place by collodion to avoid artifacts due to any kind of movement, and an experienced neurophysiologist coded the EEG using a conservative interpretation.8 In this study we used a previously described protocol9 for head-up tilt testing. First, the patients laid for 15 minutes in the supine position and subsequently were tilted at 60° for 45 minutes. The completion of the 2 test stages without symptoms indicated a negative response. The test was considered positive if syncope, defined as a sudden transient loss of consciousness with concomitant loss of postural tone and spontaneous recovery, occurred in association with hypotension, bradycardia, or both.10 As in previous studies,10 11 12 a gradual onset of minor symptoms, related to a progressive decrease in blood pressure, was regarded as a nonspecific result called "exaggerated response." In case of syncope or exaggerated response, the procedure was terminated by rapidly lowering the tilt table to the supine position.
In accordance with previous reports,10 13 14 2
main forms of positive response to head-up tilt test were identified: a
pure vasodepressor form (syncope associated with a systolic
blood pressure decrease to
60 mm Hg but without significant
heart rate reduction) and a cardioinhibitory form (syncope
associated with a systolic blood pressure decrease to
60
mm Hg and heart rate reduction to <40 bpm). All collected data are
expressed as mean±SD and analyzed by the unpaired Student
t test for continuous variables and the
2 test for categorical variables.
| Results |
|---|
|
|
|---|
Eleven of the 27 patients with a positive response during head-up tilt (40.7%) showed a significant bradycardia (mean duration of longest R-R interval on the ECG, 15.2±11.7 seconds; range, 1.8 to 40 seconds) at the time of symptom onset, associated with or rapidly followed by hypotension (mean reduction of 68.6±12.7 mm Hg for systolic and 40.9±18.9 mm Hg for diastolic blood pressure), and were considered to have a cardioinhibitory response.10 13 14 The rest of the patients with a positive response (16 of 27, 59.3%) developed hypotension (mean reduction of blood pressure of 85.8±16.6 mm Hg for systolic and 57.6±17.8 mm Hg for diastolic), with minor variations of heart rate (mean reduction of 13.4±8.7 bpm), in association with the sudden loss of consciousness and were considered to have a vasodepressor response.10 13 14 This group included significantly more females than the cardioinhibitory group (14 of 16, 87.5%, versus 4 of 11, 36.3%; P<0.01), but no significant difference was noted for age between the 2 groups.
Concomitant with the loss of consciousness, 10 of the 11 patients in the cardioinhibitory group (90.9%) showed a rigid flexed posture, followed by a rigid extended posture and bilateral myoclonic rhythmic jerks of brief duration (1 to 5 seconds). A similar pattern of convulsive syncope was noted in only 4 of 16 patients with vasodepressor syncope (25%; P<0.01). All subjects included in the control group had a negative response to head-up tilt testing.
Electroencephalography
All included subjects had a normal baseline EEG. Patients with a
negative response to the head-up tilt, including the 2 subjects with
the so-called exaggerated response, as well as all control subjects,
showed no significant EEG abnormalities or modifications during the
head-up tilt testing.
The 16 patients with a positive vasodepressor response to the head-up
tilt showed homogeneous behavior during EEG monitoring
(Figure 1
). Prodromal symptoms (nausea,
vertigo, light-headedness) (mean duration 110.6±77.7 seconds; range,
30 to 300 seconds) preceded the loss of consciousness and were not
associated with any significant EEG modification. Subsequently, the
initially normal EEG pattern was followed by a diffuse generalized
high-amplitude, 4- to 5-Hz (theta range) slowing of brain activity
starting at the moment of syncope (mean duration, 4.0±2.1 seconds;
range, 2 to 7 seconds). Such alterations were then followed by a
further increase of brain wave amplitude and slowing at 1.5 to 3 Hz
(delta range) (mean duration, 17.0±11.3 seconds; range, 6 to 47
seconds). However, no spike or spike-wave activity was recorded,
even in patients with tonic-clonic jerks (4 of 16; 25%). When patients
were returned to the supine position, the EEG showed a brief phase
(mean duration, 2.1±1.2 seconds; range, 0 to 5 seconds) of brain wave
amplitude reduction, with frequency increase to 4 to 5 Hz, followed by
the restoration of a normal EEG pattern and arousal.
|
The mean total duration of the loss of consciousness in these patients was 23.1±12.3 seconds (range, 10 to 54 seconds).
A different but again homogeneous pattern of EEG
modifications could be noted in the 11 patients with a positive
cardioinhibitory response to head-up tilt (Figure 2
).
Prodromal symptoms had a significantly shorter duration in patients
with a cardioinhibitory response than in those with a
vasodepressor response (mean duration, 8.7±6.1 seconds; range, 5 to 22
seconds; P<0,01) and were not correlated with any EEG
modification. At the onset of syncope, the initially normal EEG pattern
turned abruptly to a diffuse, generalized, high-amplitude, 4- to 5-Hz
(theta range) brain-wave slowing, rapidly followed by a further
brain-wave amplitude increase and slowing at 1.5 to 3 Hz (delta range)
(overall mean duration, 7.6±2.9 seconds; range, 5 to 14 seconds). A
sudden reduction in both amplitude and frequency of brain waves could
then be noted, leading to the disappearance of electrocerebral activity
("flat" record, with a mean duration of 15.9±13.4 seconds;
range, 1 to 46 seconds).
|
The return to the supine position allowed neither immediate resolution of the EEG abnormalities nor conscience recovery, but the complete normalization of the electrocerebral activity and the concomitant restoration of normal consciousness occurred after an additional time interval (mean duration, 15.1±6.0 seconds; range, 7 to 22 seconds). The prevalence of tonic-clonic jerks during loss of consciousness was significantly higher in patients with cardioinhibitory response (10 of 11; 90.9%) compared with patients with vasodepressor syncope (4 of 16; 25%, P<0,01). In any event, no spike or spike-wave activity or lateralizing or focal abnormalities could be detected in any patient. In patients with cardioinhibitory response, the onset of bradycardia preceded the development of EEG abnormalities (mean time, 2.9±2.5 seconds; range, 0 to 8 seconds), while the restoration of a normal cardiac rhythm was not followed by the immediate recovery of electrocerebral activity (mean time of delay, 8.1±7.1 seconds; range, 0 to 24 seconds). The mean total duration of syncope in patients with cardioinhibitory syncope was significantly longer with respect to patients with vasodepressor syncope (41.4±16.7 seconds; range, 21 to 78 seconds; P<0.01).
At the end of the test, the EEG was found to be normal in all cases and no neurological or cardiac abnormalities were noted in any patient, despite the occurrence of syncopal episodes.
| Discussion |
|---|
|
|
|---|
The only available data concerning EEG modifications during tilt-induced vasovagal syncope have been collected by Grubb and associates.17 In a recent study, these authors have performed head-up tilt testing with concurrent continuous EEG monitoring in patients with recurrent unexplained convulsive syncopal episodes.17 In these patients during tilt-induced convulsive syncope, the EEG showed diffuse generalized brain-wave slowing, but neither spike nor spike-wave activity were detected, thereby allowing differential diagnosis from epileptic seizures. Similar EEG modifications have been noted in our series in patients with tilt-induced vasodepressor vasovagal syncope, who never showed periods of flat EEG recording during the loss of consciousness.
In this study the EEG monitoring performed during head-up tilt testing allowed the recording and the complete description of the sequence and relevance of electrocerebral abnormalities taking place during a tilt-induced vasovagal syncope. These EEG alterations represent the expression of cerebral function impairment due to the critical reduction of cerebral blood flow induced by the vasovagal hypotension and bradycardia. Actually, 2 different EEG pictures have been observed which correspond and are directly related to the 2 main hemodynamic patterns that distinguish tilt-induced vasovagal syncope. A diffuse, generalized brain-wave slowing was found in patients who developed hypotension alone (vasodepressor syncope), whereas periods of electrocerebral silence (flat EEG) were always recorded in subjects with hypotension and bradycardia (cardioinhibitory syncope). Furthermore, in accordance with previous reports,18 in our experience cardioinhibitory vasovagal syncope was found to be associated with a shorter duration of prodromes, with a higher incidence of tonic-clonic jerks and a longer overall duration of syncope. These findings support the idea that the persistence of cardiac activity during a tilt-induced vasovagal episode may be associated with a milder compromise of cerebral perfusion and therefore with less-severe clinical manifestations. Even if collected data cannot be considered as conclusive, such a hypothesis is somehow strengthened by the evidence that bradycardia support by cardiac pacing can, in some cases, ameliorate or resolve cardioinhibitory vasovagal episodes.19 20 21 22
Limitations of the Study
The observations of this study have been collected in a
controlled laboratory setting in which syncope has been induced with a
standardized procedure. Therefore, recorded events may not fully
correspond to spontaneous syncopal episodes, as already noted by
several authors.23 24 In particular, spontaneous
syncope determines a loss of postural tone with a consequent sudden
fall; such an event allows immediate recovery of cerebral blood flow
and is considered a protective mechanism. Because in head-up tilt
testing patients are secured to the table, the return to the supine
position may take a period of time, which depends on the technical
characteristics of the different laboratory tables. This time
interval may contribute to the relevance of symptoms and
hemodynamic and EEG modifications. In this study, an
electronically controlled tilt table has been used, taking up to 18
seconds to reach the horizontal plane; this time interval may be too
long, possibly contributing to the dramatic picture of both
hemodynamic and EEG modification in patients with
syncope. Consequently, tilt tables with a short travel time to the
horizontal plane should be preferred in order to reduce the overall
duration of syncope. However, in some rare cases this situation might
occur also spontaneously, as in patients whose body position at the
beginning of the vasovagal reflex (eg, sitting, driving, or standing in
small and restricted places) does not allow them to immediately reach
the supine position. In addition, in this study blood pressure was
discontinuously measured by a standard mercury sphygmomanometer during
the head-up tilt testing. Such methodology may represent a
limit, particularly in those patients showing brief prodromes or
unheralded syncope, as a rapidly developing blood pressure fall could
not be properly recorded.
Received December 30, 1997; revision received August 3, 1998; accepted August 24, 1998.
| References |
|---|
|
|
|---|
2. Abboud FM. Ventricular syncope. N Engl J Med. 1989;32:390392.
3. Kapoor WN. Work-up and management of patients with syncope. Med Clin North Am. 1995;79:11531170.[Medline] [Order article via Infotrieve]
4. Binnie CD. Electroencephalography. In: Laidlaw J, Richens A, Oxley J, eds. A Textbook of Epilepsy. 3rd ed. Edinburgh, Scotland: Churchill Livingstone; 1988:236306.
5. Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet. 1986;1:13521355.[Medline] [Order article via Infotrieve]
6. Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kubler J, Lerman BB, Maloney JD, Raviele A, Ross B, Sutton R, Wolk MG, Wood DL. Tilt table testing for assessing syncope: ACC Expert Consensus Document. J Am Coll Cardiol. 1996;28:263275.[Medline] [Order article via Infotrieve]
7. Engel J Jr. Differential diagnosis of seizures. In: Engel J Jr, ed. Seizures and Epilepsy. Philadelphia, Pa: FA Davis Co; 1989:340341.
8. Engel J Jr. A practical guide for routine EEG studies in epilepsy. J Clin Neurophysiol. 1984;1:109142.[Medline] [Order article via Infotrieve]
9. Fitzpatrick AP, Thedorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 1991;17:125130.[Abstract]
10. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med. 1994;97:7888.[Medline] [Order article via Infotrieve]
11. Raviele A, Gasparini G, Di Pede F, Menozzi C, Brignole M, Dinelli M. Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J. 1994;127:103111.[Medline] [Order article via Infotrieve]
12. Ammirati F, Colivicchi F, Biffi A, Magris B, Pandozi C, Santini M. Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: a simplified time-saving approach for the evaluation of unexplained syncope. Am Heart J. 1998;135:671676.[Medline] [Order article via Infotrieve]
13. Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A. Carotid sinus massage, eyeball compression and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects. Am Heart J. 1991;122:16441651.[Medline] [Order article via Infotrieve]
14. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol. 1992;3:180183.
15. Gastaut H. Syncopes: generalised anoxic cerebral seizures. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam, Netherlands: Elsevier; 1974:836852.
16. Daly DD. Epilepsy and syncope. In: Daly DD, Pedley TA, eds. Current Practice of Clinical Electroencephalography. New York, NY: Raven Press Publishers; 1990:269334.
17. Grubb BP, Gerard G, Roush K, Temesey-Armos P, Elliott L, Hahn H, Spann C. Differentiation of convulsive syncope and epilepsy with head-up tilt testing. Ann Intern Med. 1991;115:871876.
18.
Fitzpatrick AP, Thedorakis G, Vardas P, Kenny RA,
Travil CM, Ingram A, Sutton R. The incidence of malignant vasovagal
syncope with recurrent syncope. Eur Heart J. 1991;12:389394.
19. Fitzpatrick AP, Theodorakis G, Ahmrd R, Williams T, Sutton R. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degree tilt. Pacing Clin Electrophysiol. 1991;14:1319.[Medline] [Order article via Infotrieve]
20.
Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP,
Ingram A, Williams T, Sutton R. Permanent pacing for
cardioinhibitory malignant vasovagal syndrome. Br
Heart J. 1994;71:274281.
21. Ammirati F, Colivicchi F, Altamura G, Laudadio MT, De Seta F, Santini M. DDD pacing with rate-drop response function versus DDI pacing for cardioinhibitory vasovagal syncope. Pacing Clin Electrophysiol. 1998;21(part II):825. Abstract.
22.
Sra JS, Jazayeri MR, Avitall B, Dhala A, Deshpande S,
Blanck Z, Akhtar M. Comparison of cardiac pacing with drug therapy in
the treatment of neurocardiogenic (vasovagal) syncope with bradycardia
or asystole. N Engl J Med. 1993;328:10851090.
23. Brignole M, Menozzi C. Methods other than tilt testing for diagnosing neurocardiogenic (neurally mediated) syncope. Pacing Clin Electrophysiol. 1997;20(part II):795800.
24. Grubb BP, Kosinski D Tilt table testing: concepts and limitations. Pacing Clin Electrophysiol. 1997;20(part II):781787.
This article has been cited by other articles:
![]() |
E. Martinez-Fernandez, F. B. Garcia, J.R. Gonzalez-Marcos, A. G. Peralta, A. G. Garcia, and A. M. Deya Clinical and Electroencephalographic Features of Carotid Sinus Syncope Induced by Internal Carotid Artery Angioplasty AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 269 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Passman, G. Horvath, J. Thomas, J. Kruse, A. Shah, J. Goldberger, and A. Kadish Clinical Spectrum and Prevalence of Neurologic Events Provoked by Tilt Table Testing Arch Intern Med, September 8, 2003; 163(16): 1945 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Colivicchi, F. Ammirati, A. Biffi, L. Verdile, A. Pelliccia, and M. Santini Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome Eur. Heart J., July 2, 2002; 23(14): 1125 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schondorf, R. Stein, R. Roberts, J. Benoit, and W. Cupples Dynamic cerebral autoregulation is preserved in neurally mediated syncope J Appl Physiol, December 1, 2001; 91(6): 2493 - 2502. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Santini, F Ammirati, F Colivicchi, G Gentilucci, and V Guido The effect of atropine in vasovagal syncope induced by head-up tilt testing Eur. Heart J., December 1, 1999; 20(23): 1745 - 1751. [Abstract] [PDF] |
||||
![]() |
M. L. Dyken Stroke, November 1, 1999; 30 (11): 2493 - 2494. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |